EFFECT OF DAILY ORAL VITAMIN D AND CALCIUM THERAPY, HYPOPHOSPHATEMIA, AND ENDOGENOUS 1–25 DIHYDROXYCHOLECALCIFEROL ON PARATHYROID HORMONE AND PHOSPHATE WASTING IN RENAL TRANSPLANT RECIPIENTS